Project Number 5P01AG020206-07 Agency/Funding Organization NIA Funding Year 2010 View Full Project Details for CLINICAL STUDIES OF NSAIDSS AS Y-SECRETASE MODULATORS IN ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator GALASKO, DOUGLAS R Principal Investigator First Name DOUGLAS Principal Investigator Last Name GALASKO Awardee Organization UNIVERSITY OF CALIFORNIA SAN DIEGO Awardee State California Contact PI Country United States Project Detail FY Overall Cost $624,949 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO Related Resources Repository [AlzPED] Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice. [AlzPED] NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ 42 in vivo.
